Trial Profile
An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Beta lapachone (Primary)
- Indications Solid tumours
- Focus Biomarker; Pharmacodynamics
- Sponsors ArQule
- 17 Oct 2011 Actual end date (August 2008) added as reported by ClinicalTrials.gov.
- 04 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.